This inventor holds 2 USPTO granted patents. Top assignee: Genesis Research & Development Corporation Limited. Active years: 1999.
Location History:
- Westmere, NZ (1999)
- Auckland, NZ (1999)
Company Filing History:
Years Active: 1999
Title: The Innovative Contributions of Margot Skinner
Introduction
Margot Skinner, an accomplished inventor based in Westmere, New Zealand, has made significant strides in the field of immunology. With two patents to her name, her work focuses on advancing treatments and diagnostic methods for mycobacterial infections, showcasing her dedication to improving public health.
Latest Patents
Margot's latest patents include groundbreaking inventions centered around Mycobacterium vaccae antigens. The first patent presents polypeptides comprising an immunogenic portion of a M. vaccae soluble protein, along with DNA molecules encoding such polypeptides. These innovations offer methods for diagnosing and treating mycobacterial infections effectively. The second patent similarly covers polypeptides with immunogenic properties of M. vaccae and their potential applications in enhancing immune responses through the administration of M. vaccae culture filtrate or delipidated M. vaccae cells. These patents reflect Margot's innovative approach to tackling complex health challenges.
Career Highlights
Margot Skinner works with Genesis Research & Development Corporation Limited, where her expertise and pioneering ideas contribute to the company's mission of developing advanced biomedical solutions. Her work in this prestigious institution had positioned her as a key figure in her field, influencing both research and practical applications related to mycobacterial infections.
Collaborations
Margot collaborates with esteemed colleagues, including Paul L Tan and Ross L Prestidge. Together, they share insights and expertise, fostering an environment of innovation and creativity in their research endeavors. Their combined efforts aim to make significant advancements in the medical field, particularly concerning immunological challenges.
Conclusion
The contributions of Margot Skinner to the field of immunology and her innovative patents on Mycobacterium vaccae antigens demonstrate her commitment to enhancing healthcare solutions. Her work at Genesis Research & Development Corporation Limited, alongside notable collaborators, promises to pave the way for improved diagnosis and treatment of mycobacterial infections. Margot's dedication to her work serves as an inspiration to others in the realm of scientific research and innovation.